Pathologie van coronaire atherotrombose

  • A. C. van der Wal


Atherosclerose is een ziekte die zich manifesteert in de intima van grote (aorta) en middelgrote arteriën (het kaliber van de a. coronaria) in de vorm van focaal verheven laesies, de atherosclerotische plaques. Deze plaques bestaan uit een kern van lipidenrijk debris (atheroom) en kalk, omgeven door een fibreuze kap van collageenrijk bindweefsel en cellen, die bedekt wordt door een laag endotheel.


  1. 1.
    Fuster V, Gotto AM, Libby P, Loscalzo J, McGill HC. Task Force 1. Pathogenesis of coronary disease: the biologic role of risk factors. J Am Coll Cardiol 1996;27:964–76.PubMedCrossRefGoogle Scholar
  2. 2.
    Kádár A, Mozes G, Illyes Gy, et al. World Health Organization (WHO) and the World Heart Federation (WHF) Pathobiological Determinants of Atherosclerosis in Youth Study (WHO/WHF PBDAY Study) 1986–1996. Histomorphometry and histochemistry of atherosclerotic lesions in coronary arteries and the aorta in a young population. Nutr Metab Cardiovasc Dis 1999;9:220–7.PubMedGoogle Scholar
  3. 3.
    Wal AC van der, Becker AE. Atherosclerotic plaque rupture – pathologic basis of plaque stability and instability. Cardiovasc Res 1999;41:334–44.PubMedCrossRefGoogle Scholar
  4. 4.
    Enos WF, Holms RH, Beyer J. Coronary artery disease among United States soldiers killed in action in Korea: preliminary report. JAMA 1953;152:1090–3.CrossRefGoogle Scholar
  5. 5.
    Davies MJ. A macro and micro view of coronary vascular insult in ischemic heart disease. Circulation 1990;82(3 Suppl):1138-46.Google Scholar
  6. 6.
    Gutstein DE, Fuster V. Pathophysiology and clinical significance of plaque rupture. Cardiovasc Res 1999;41:323–33.PubMedCrossRefGoogle Scholar
  7. 7.
    Ross R, Glomset JRA. The pathogenesis of atherosclerosis. N Engl J Med 1976;295: 369-77/420-5.PubMedCrossRefGoogle Scholar
  8. 8.
    Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med 1999;340:115–26.PubMedCrossRefGoogle Scholar
  9. 9.
    Zarins C, Giddens DP, Glagov S. Carotid bifurcation atherosclerosis: quantitative correlation of plaque localization with flow velocity profiles and shear stress. Circ Res 1983;53:502–14.PubMedCrossRefGoogle Scholar
  10. 10.
    Wal AC van der, Becker AE, Elbers JRJ, Das PK. An immunocytochemical analysis of rapidly progressive atherosclerosis in human vein grafts. Eur J Cardiothoracic Surg 1992;6:469–74.CrossRefGoogle Scholar
  11. 11.
    Gimbrone MA, Cybulsky MI, Kume N, et al. Vascular endothelium – an integrator of pathophysiological stimuli in atherogenesis. Ann N Y Acad Sci 1995;748: 122–32.PubMedCrossRefGoogle Scholar
  12. 12.
    Watson AD, Leitinger N, Navab M, et al. Structural identification by mass spectrophotometry of oxidized phospholipids in minimally oxidized LDL that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem 1997;272:13597–607.PubMedCrossRefGoogle Scholar
  13. 13.
    Hansson GK. Inflammation, atherosclerosis and coronary artery disease. N Engl J Med 2005;352:1585–98.CrossRefGoogle Scholar
  14. 14.
    Mitchinson MJ, Ball RY, Carpenter KLH, et al. Macrophages and ceroid in human atherosclerosis. Eur Heart J 1990;11(Suppl E):116–21.PubMedCrossRefGoogle Scholar
  15. 15.
    Boer OJ de, Becker AE, Wal AC van der. T-lymphocytes in atherogenesis – functional aspects and antigenic repertoire. Cardiovasc Res 2003;60(1):78–86.PubMedCrossRefGoogle Scholar
  16. 16.
    Johnson RC, Leopold JA, Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 2006;99:1044–59.PubMedCrossRefGoogle Scholar
  17. 17.
    Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histologic classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol 1995;15:1512–31.PubMedCrossRefGoogle Scholar
  18. 18.
    Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20:1262–127.PubMedCrossRefGoogle Scholar
  19. 19.
    Davies MJ. Going from immutable to mutable atherosclerotic plaques. Eur Heart J 2001;88:2–8.Google Scholar
  20. 20.
    Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995;92:657–71.PubMedCrossRefGoogle Scholar
  21. 21.
    Burke A, Farb A, Malcom G, Liang Y-H, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary heart disease who died suddenly. N Engl J Med 1997;336:1276–82.PubMedCrossRefGoogle Scholar
  22. 22.
    Farb A, Burke A, Tang A, et al. Coronary plaque erosion without a rupture into the lipid core: a frequent cause of coronary thrombosis in sudden death. Circulation 1996;93:1354–63.PubMedCrossRefGoogle Scholar
  23. 23.
    Wal AC van der, Becker AE, Loos CM van der, Das PK. Site of intimal rupture or erosion of thrombosed coronary plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89: 36–44.PubMedCrossRefGoogle Scholar
  24. 24.
    Henriques de Gouveia R, Wal AC van der, Becker AE. Sudden unexpected death in young adults – discrepancies between initiation of acute plaque complications and the onset of acute coronary death. Eur Heart J 2002;23:1433–40.CrossRefGoogle Scholar
  25. 25.
    Ambrose J, Winters S, Arora R, et al. Coronary angiography morphology in acute myocardial infarction: link between the pathogenesis of unstable angina and myocardial infarction. J Am Coll Cardiol 1985;6:1233–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Meuwissen M, Wal AC van der, Koch KT, Loos CM van der, Chamuleau SA, Teeling P, Winter RJ de, Tijssen JG, Piek JJ. Association between complex coronary artery stenosis and unstable angina and the extent of plaque inflammation, Am J Med 2003;114:521–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Falk E, Thuessen L. Pathology of coronary microembolisation and no reflow. Heart. 2003;89:983–5.PubMedCrossRefGoogle Scholar
  28. 28.
    Lindahl B, Venge P, Wallentin L, et al. Troponin T identifies patients with unstable coronary artery disease who benefit from long term antithrombotic protection. J Am Coll Cardiol 1997;29:43–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Davies MJ, Bland JM, Hangartner JW, et al. Factors influencing the presence or absence of acute coronary artery thrombi in sudden death. Eur Heart J 1989;10: 203–8.PubMedGoogle Scholar
  30. 30.
    Mann J, Davies MJ. Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart 1999;82:265–8.PubMedGoogle Scholar
  31. 31.
    Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, Wrenn SP, Narula J. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005 Oct;25(10):2054–61PubMedCrossRefGoogle Scholar
  32. 32.
    Schaar JA, Muller JE, Falk E, Virmani R, Fuster V, Serruys PW, Colombo A, Stefanadis C, Ward Casscells S, Moreno PR, Maseri A, Steen AF van der. Terminology for high risk and vulnerable plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece. Eur Heart J 2004;25: 1262–75.CrossRefGoogle Scholar
  33. 33.
    Glagov S, Weisenberg E, Zarins CK, et al. Compensatory enlargement of human atherosclerotic arteries. N Engl J Med 1986;316:1371–5.CrossRefGoogle Scholar
  34. 34.
    Pasterkamp G, Schoneveld AH, Wal AC van der, et al. The relation of arterial geometry with luminal narrowing and histological markers for plaque vulnerability: the remodeling paradox. J Am Coll Cardiol 1998;32:606–12.CrossRefGoogle Scholar
  35. 35.
    Smits PC, Pasterkamp G, Jaegere PT de, et al. Angioscopic complex lesions are compensatory enlarged. An angioscopy and intracoronary ultrasound study. Cardiovasc Res 1999;41:458–64.PubMedCrossRefGoogle Scholar
  36. 36.
    Muller JE, Abela GS, Nesto RW, et al. Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. J Am Coll Cardiol 1994;23:809–13.PubMedCrossRefGoogle Scholar
  37. 37.
    Koenig W. Haemostatic risk factors for cardiovascular diseases. EurHeart J 1998;19 (Suppl C):39–43.Google Scholar
  38. 38.
    Aikawa M, Rabkin E, Okada Y, et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation 1998;97:2433–4.PubMedCrossRefGoogle Scholar
  39. 39.
    Hernandes-Perera O, Perez-Sala D, Navarro-Antolin J, et al. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors atorvastatin and simvastatin on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest 1998;101:2711–9.CrossRefGoogle Scholar

Copyright information

© Eerste druk 2008

Authors and Affiliations

  • A. C. van der Wal
    • 1
  1. 1.Academisch Medisch CentrumAmsterdamNetherlands

Personalised recommendations